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Abstract
The additive Calsporin® is a preparation of viable spores of Bacillus subtilis DSM 15544, at a minimum
declared concentration of 1 9 1010 colony forming units (CFU)/g additive. The additive is authorised as a
zootechnical additive (functional group: gut ﬂora stabiliser) for use in chickens for fattening, weaned
piglets, chickens reared for laying, turkeys, minor avian species and other ornamental and game birds,
laying hens and ornamental ﬁsh, dogs, in sows and in suckling piglets. This opinion concerns a request
for a modiﬁcation of the terms of the authorisation, reducing the minimum content in complete feed for
chickens for fattening from the authorised concentration of 5 9 108 CFU/kg feed to a concentration of
3 9 108 CFU/kg feed and for an authorisation for the use of the additive for all poultry species. The
active agent fulﬁls the requirements of the qualiﬁed presumption of safety (QPS) approach to the
assessment of safety and no concerns are expected from other components of the additive.
Consequently, Calsporin® is considered safe for the target animals, the consumers and for the
environment. The additive is not a dermal/eye irritant or a skin sensitiser but should be considered a
potential respiratory sensitiser. The additive has the potential to be efﬁcacious as a zootechnical additive
in feedingstuffs for chickens for fattening at the level of 3 9 108 CFU/kg complete feed. Considering that
efﬁcacy at the same level has been shown in laying hens and turkeys, this conclusion is extrapolated to
all poultry species and categories.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 13(3) of that Regulation lays down that if the
holder of an authorisation proposes changing the terms of the authorisation by submitting an
application to the Commission, accompanied by the relevant data supporting the request for the
change, the Authority shall transmit its opinion on the proposal to the Commission and the Member
States, and Article 4(1) of that Regulation lays down that any person seeking authorisation for a feed
additive or for a new use of a feed additive shall submit an application in accordance with Article 7.
The European Commission received a request from Asahi Calpis Wellness Co. Ltd.2 for modiﬁcations
of the terms of authorisation and for authorisation of the product Calsporin® (Bacillus subtilis DSM
15544), when used as a feed additive for all poultry species (category: zootechnical additives;
functional group: gut ﬂora stabilisers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 13(3)
(modiﬁcation of the authorisation of a feed additive) and under Article 4(1) (authorisation of a feed
additive or new use of a feed additive). EFSA received directly from the applicant the technical dossier
in support of this application. The particulars and documents in support of the application were
considered valid by EFSA as of 12/10/2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether the
feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety
for the target animals, consumer, user and the environment and on the efﬁcacy of the product Calsporin®
(Bacillus subtilis DSM 15544), when used under the proposed ll conditions of use .
1.2. Additional information
The additive Calsporin® is a preparation containing viable spores of a single strain of Bacillus
subtilis DSM 15544. EFSA has issued several opinions on the safety and efﬁcacy of Calsporin® as a
feed additive for different species: chickens for fattening (EFSA, 2006, 2007a,b; EFSA FEEDAP Panel,
2018a), weaned piglets (EFSA FEEDAP Panel, 2010a), turkeys for fattening, ducks, geese, pigeons and
other game birds for meat production, ducks, geese, pigeons, game birds, ornamental and sporting
birds for rearing to point of lay, turkeys reared for breeding and chickens reared for laying (EFSA
FEEDAP Panel, 2010b), laying hens and avian species for laying (EFSA FEEDAP Panel, 2015a),
ornamental ﬁsh (EFSA FEEDAP Panel, 2015b), sows and suckling piglets (EFSA FEEDAP Panel, 2017a),
dogs (EFSA FEEDAP Panel, 2017b) and pigs for fattening (EFSA FEEDAP Panel, 2018b).
The additive is authorised as a zootechnical additive (functional group: gut ﬂora stabiliser) for use
in chickens for fattening,3 weaned piglets,4 chickens reared for laying, turkeys, minor avian species
and other ornamental and game birds,5 laying hens and ornamental ﬁsh,6 dogs and sows.7
1 Commission Regulation (EC) No 1444/2006 of 29 September 2006 concerning the authorisation of Bacillus subtilis C-3102
(Calsporin) as a feed additive. OJ L 271, 30.9.20.
2 Asahi Calpis Wellness Co. Ltd., Japan, represented in Europe by Asahi Calpis Wellness Co. Ltd. Europe Representative Ofﬁce, 46
rue Paul Valery, 75116, Paris, France.
3 Commission Regulation (EC) No 1444/2006 of 29 September 2006 concerning the authorisation of Bacillus subtilis C-3102
(Calsporin) as a feed additive. OJ L 271, 30.9.2006, p. 19 plus amendments.
4 Commission Regulation (EU) No 333/2010 of 22 April 2010 concerning the authorisation of a new use of Bacillus subtilis C-3102
(DSM 15544) as a feed additive for weaned piglets (holder of authorisation Calpis Co. Ltd. Japan, represented in the European
Union by Calpis Co. Ltd. Europe Representative Ofﬁce). OJ L 102, 23.4.2010, p. 19 plus amendments.
5 Commission Regulation (EU) No 184/2011 of 25 February 2011 concerning the authorisation of Bacillus subtilis C-3102 (DSM
15544) as a feed additive for chickens reared for laying, turkeys, minor avian species and other ornamental and game birds
(holder of authorisation Calpis Co. Ltd Japan, represented by Calpis Co. Ltd Europe Representative Ofﬁce). OJ L 53, 26.2.2011,
p. 33 plus amendments.
6 Commission Implementing Regulation (EU) 2016/897 of 8 June 2016 concerning the authorisation of a preparation of Bacillus
subtilis (C-3102) (DSM 15544) as a feed additive for laying hens and ornamental ﬁsh (holder of authorisation Asahi Calpis
Wellness Co. Ltd) and amending Regulations (EC) No 1444/2006, (EU) No 333/2010 and (EU) No 184/2011 as regards the
holder of the authorisation. OJ L 152, 9.6.2016, p. 7.
7 Commission Implementing Regulation (EU) 2017/2312 of 13 December 2017 concerning the authorisation of a new use of the
preparation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for sows, suckling piglets and dogs (holder of the
authorisation Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Ofﬁce), OJ L
331, 14.12.2017, p. 41.
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The applicant is asking for a modiﬁcation of the terms of the authorisation, reducing the minimum
content in complete feed for chickens for fattening from the authorised concentration of 5 9 108 colony
forming units (CFU)/kg feed to a concentration of 3 9 108 CFU/kg feed; in addition, the applicant is
asking for an authorisation for the use of the additive for all poultry species. It is noted that, except for
chickens for fattening, which are subject of the current opinion, the additive is already currently
authorised at 3 9 108 CFU/kg feed for all the remaining poultry species (laying hens and minor laying
poultry species, turkeys and minor growing poultry species).
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier8 in support of the authorisation request for the use of Calsporin® (Bacillus subtilis DSM 15544)
as a feed additive.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA, to deliver the present output.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment regarding the methods used for the control of
the active substance/agent in animal feed/marker residue in tissues are valid and applicable for the
current application.9
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Calsporin® is
in line with the principles laid down in Regulation (EC) No 429/2008, the relevant guidance documents:
Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012) and Technical guidance on tolerance
and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011a,b).
3. Assessment
Calsporin® is a preparation of viable spores of a single strain of B. subtilis intended for use as a
zootechnical additive (gut ﬂora stabiliser) in all poultry species. The additive is currently authorised for
use in laying hens, turkeys, minor avian species and other ornamental and game birds at a minimum
content of 3 9 108 CFU/kg feed, and for chickens for fattening and chickens reared for laying at a
minimum content of 5 9 108 CFU/kg feed. The applicant is now requesting the reduction of the
minimum content in complete feed for chickens for fattening to 3 9 108 CFU/kg feed and the
authorisation for the use of the additive for all poultry species.
3.1. Characterisation
The active agent is a B. subtilis strain deposited in the German Collection of Microorganisms and
Cell Cultures with accession number DSM 15544 and in the National Institute of Advanced Industrial
Science and Technology (Japan) with accession number FERM BP-1096. The identity of the strain has
been previously demonstrated using molecular methods (full 16S rRNA gene sequencing and pulsed
ﬁeld gel electrophoresis (PFGE)).10 The PFGE patterns of the strain isolated from one batch of the
product from 2015 were identical to those from the strain deposited (DSM 15544), conﬁrming that the
strain has not been modiﬁed over time (EFSA FEEDAP Panel, 2018a). Susceptibility to relevant
antibiotics and lack of toxigenic potential were conﬁrmed in a previous opinion (EFSA FEEDAP Panel,
2015a) and are considered still valid.
The additive is a preparation of viable spores of Bacillus subtilis DSM 15544 at a minimum declared
concentration of 1 9 1010 CFU/g additive. It has the same formulation (
) and method of manufacture as that considered in previous opinions (EFSA,
2006; EFSA FEEDAP Panel, 2010a,b, 2015a). Thus, the data pertaining to composition, impurities,
physical properties and shelf life still apply.
8 FEED dossier reference: FAD-2018-0062.
9 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/files/FinRep-FAD-2009-0013.pdf
10 Technical dossier/Supplementary information October 2016/Annexes II.2.1.2.1–II.2.1.2.3.
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The stability of the additive and its capacity to homogeneously distribute in feed has also been
previously demonstrated in feed for chickens for fattening (EFSA, 2006; EFSA FEEDAP Panel, 2010a,b,
2018a).
Calsporin® is proposed to be used in feeds for all poultry species at a minimum recommended dose
of 3 9 108 CFU/kg complete feed.
3.2. Safety
The species B. subtilis is considered by EFSA to be suitable for the qualiﬁed presumption of safety
(QPS) approach to establish safety for the target species, consumers and the environment (EFSA,
2007a,b; EFSA BIOHAZ Panel, 2018). This approach requires the identity of the active agent to be
established and the absence of a toxigenic potential and susceptibility to antibiotics of human clinical
and veterinary importance to be demonstrated. The identity of the strain Calsporin® (Bacillus subtilis
DSM 15544) was established and the lack of resistance to relevant antibiotics and of toxigenic
potential was demonstrated in a previous assessment (EFSA FEEDAP Panel, 2015a). Accordingly, this
strain is considered by EFSA to be suitable for the QPS approach to safety and the additive is
presumed safe for the target species, consumers and for the environment.
In the context of the renewal of the authorisation of Calsporin® for chickens for fattening, the
FEEDAP Panel concluded that Calsporin is safe for the target species, consumers of products from
animals fed the additive and for the environment. The additive is not a dermal/eye irritant or a skin
sensitiser but should be considered a potential respiratory sensitiser (EFSA FEEDAP Panel, 2018a).
The proposed reduction in the minimum recommended use level would not impact the conclusions
on the safety of the product. Likewise, the extension of use to all poultry species would not introduce
hazards other than those already considered in the previous assessments.
Therefore, the FEEDAP Panel concludes that Calsporin®, under the proposed conditions of use is
safe for target species, consumers, users and the environment.
3.3. Efﬁcacy
A total of four trials sharing a common design and performed in chickens for fattening were
submitted. The studies were conducted in two Member States. The details on the study design are
provided in Table 1 and the main results in Table 2. In all trials, 1-day-old male birds (average body
weight 44 g) were used. In all trials, a basal diet was either unsupplemented (control) or
supplemented with Calsporin® (30 mg/kg feed) to provide 3 9 108 CFU/kg feed (conﬁrmed by
analysis). The diets were administered ad libitum for 42 days. The health of the birds and mortality
were monitored throughout the study and the body weight and feed intake were recorded on days 21
and 42. Feed to gain ratio was calculated. In each study, the data on the zootechnical parameters and
the mortality were analysed with an analysis of variance (ANOVA), using the pen as the experimental
unit. Statistical signiﬁcance level was set at 0.05.
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The supplementation of diets for chickens for fattening with Calsporin® supplying 3 9 108 CFU/kg
complete feed had a beneﬁcial effect on the total weight gain and feed to gain ratio in two trials (trials
2 and 3) and reduced mortality in trial 3 only. No effects on zootechnical parameters were observed in
the other two trials.
The data from the four studies were pooled and analysed statistically.11 The analysis included the
following parameters: weight gain, feed intake, feed to gain ratio and mortality. An ANOVA, which took
into account the effect of the treatment, the effect of the trial and their interaction, was performed;
differences were considered signiﬁcant at a level of at least p < 0.05. The results showed that the
supplementation of the feed with Calsporin® improved signiﬁcantly the total weight gain (2.27 vs
2.30 kg for control and Calsporin®), the feed to gain ratio (1.96 vs 1.94 for control and Calsporin®)
and reduced the mortality (3.56% vs 2.85% for control and Calsporin®). Based on the results of the
pooled data, the Panel concludes that the additive has the potential to be efﬁcacious in chickens for
fattening at the newly proposed minimum content of 3 9 108 CFU/kg compete feed. This conclusion
can be extended to chickens reared for laying.
Table 1: Trial design and dosages of the efﬁcacy trials performed in chickens for fattening
Trial
Total no of animals
(animals 3 replicate)
replicates 3 treatment
Breed sex
(duration)
Composition feed (Form)
Groups (CFU/kg feed)
Intended Analysed§
1(a) 2,560
(40)
16
Ross 308
Males
(42 days)
Wheat, barley*, soya bean
meal (Mash)
0
3 9 108
–
2.3 9 108
2(b) 2,240
(35)
16
Ross 308
Males
(42 days)
Wheat, barley*, soya bean
meal (Mash)
0
3 9 108
–
2.6 9 108
3(c) 2,240
(35)
16
Ross 308
Males (42
days)
Wheat, barley*, soya bean
meal (Mash)
0
3 9 108
–
3 9 108
4(d) 306
(9)
17
Ross 308
Males
(42 days)
Wheat, soya bean meal
(Mash)
0
3 9 108
–
2.8 9 108
CFU: colony forming unit.
*: In the grower diets only (days 21–42).
§: Mean of starter and grower diets.
(a): Technical dossier/Section IV/Annex_IV_3_1.
(b): Technical dossier/Section IV/Annex_IV_3_2.
(c): Technical dossier/Section IV/Annex_IV_3_3.
(d): Technical dossier/Section IV/Annex_IV_3_4.
Table 2: Effects of Calsporin® on the performance of chickens for fattening (trials 1, 2 and 3)
Trial
Groups (CFU/kg
feed)
Feed intake1
(kg)
Weight gain2
(kg)
Feed to gain
ratio
Mortality and culling
(%)
1 0 4.66 2.39 1.95 6.0
3 9 108 4.69 2.40 1.96 6.9
2 0 4.26 2.17b 1.96a 1.8
3 9 108 4.29 2.21a 1.94b 1.1
3 0 4.53 2.26b 2.01a 3.0a
3 9 108 4.56 2.30a 1.98b 1.4b
4 0 0.101 0.054 1.85 3.3
3 9 108 0.099 0.054 1.83 1.3
CFU: colony forming unit.
a,b: Mean values within a trial and within a column with a different superscript are signiﬁcantly different p < 0.05.
1: Total feed intake in studies 1, 2 and 3; average daily feed intake in study 4.
2: Total weight gain in studies 1, 2 and 3; average daily weight gain in study 4.
11 Technical dossier/Section IV/Annex_IV_3_5.
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The efﬁcacy of the additive Calsporin® at the same minimum concentration of 3 9 108 CFU/kg
complete feed was previously demonstrated in laying hens and turkeys. The conclusions on the
efﬁcacy of the additive are therefore extrapolated to all poultry species.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation12 and Good
Manufacturing Practice.
4. Conclusions
The active agent fulﬁls the requirements of the QPS approach to the assessment of safety and no
concerns are expected from other components of the additive. Consequently, Calsporin® is considered
safe for the target animals, the consumers and for the environment. The additive is not a dermal/eye
irritant or a skin sensitiser but should be considered a potential respiratory sensitiser.
The additive has the potential to be efﬁcacious as a zootechnical additive in feedingstuffs for
chickens for fattening at the level of 3 9 108 CFU/kg complete feed. Considering that efﬁcacy at the
same level has been shown in laying hens and turkeys, this conclusion is extrapolated to all poultry
species and categories.
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